You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

adenovirus-36

Showing 26 - 50 of 3,619
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Adenovirus Infection Trial in Columbus (Adenovirus Specific T lymphocytes)

Recruiting
  • Adenovirus Infection
  • Adenovirus Specific T lymphocytes
  • Columbus, Ohio
    Nationwide Children's Hospital
Sep 1, 2022

COVID-19 Trial in Wuhan (Prototype and Omicron BA.4/5 Bivalent Recombinant COVID-19 Vaccine(Adenovirus Type 5 Vector) For

Recruiting
  • COVID-19
  • Prototype and Omicron BA.4/5 Bivalent Recombinant COVID-19 Vaccine(Adenovirus Type 5 Vector) For Inhalation
  • +2 more
  • Wuhan, Hubei, China
    Zhongnan Hospital of Wuhan University
Jun 1, 2023

Adenovirus, Primary Immune Deficiency Disorder Trial in United States (cytotoxic t-lymphocytes)

Recruiting
  • Adenovirus
  • Primary Immune Deficiency Disorder
  • cytotoxic t-lymphocytes
  • Los Angeles, California
  • +8 more
Sep 27, 2022

Human Immunodeficiency Virus Trial in Bangkok (Ad26.Mos.HIV, MVA-Mosaic, Placebo)

Completed
Has Results
  • Human Immunodeficiency Virus
  • Ad26.Mos.HIV
  • +2 more
  • Bangkok, Thailand
    (unnamed)
Dec 29, 2021

Untreated Advanced NSCLC Trial in Fuzhou (Recombinant human adenovirus type 5 injection (H101) combined with tirilizumab and

Recruiting
  • Untreated Advanced Non-small Cell Lung Cancer
  • Recombinant human adenovirus type 5 injection (H101) combined with tirilizumab and platinum-containing two-drug chemotherapy
  • Fuzhou, Fujian, China
    Fujian Cancer Hospital
Nov 13, 2023

Malignant Glioma of Brain, Astrocytoma, Malignant Astrocytoma Trial in Detroit (Ad5-yCD/mutTKSR39rep-ADP adenovirus and

Recruiting
  • Malignant Glioma of Brain
  • +8 more
  • Ad5-yCD/mutTKSR39rep-ADP adenovirus and fractionated stereotactic radiosurgery (fSRS)
  • Detroit, Michigan
    Henry Ford Health System
Jan 9, 2023

Hemophilia A, Gene Therapy, Clotting Disorders Trial in Johannesburg, London, Southampton (Valoctocogene Roxaparvovec)

Recruiting
  • Hemophilia A
  • +3 more
  • Valoctocogene Roxaparvovec
  • Seoul, Korea, Republic of
  • +8 more
Jan 6, 2023

COVID-19 Trial in Taizhou (Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector), Recombinant Novel Coronavirus

Completed
  • COVID-19
  • Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector)
  • Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) -placebo
  • Taizhou, Jiangsu, China
    Taixing City center for Disease Control and Prevention
Oct 28, 2022

HIV-1-infection Trial in Brazil, United States (ChAdOx1.tHIVconsv1, ChAdOx1.HIVconsv62, MVA.tHIVconsv3)

Not yet recruiting
  • HIV-1-infection
  • ChAdOx1.tHIVconsv1
  • +7 more
  • San Diego, California
  • +11 more
Oct 4, 2023

Parkinson Disease, Multiple Sclerosis, Stroke Trial (Turkish Validity and Reliability of The MAM-36 Scale)

Completed
  • Parkinson Disease
  • +3 more
  • Turkish Validity and Reliability of The MAM-36 Scale
  • (no location specified)
Nov 3, 2023

Healthy Trial in Mount Pleasant (Ad26.RSV.preF, Fluarix, Placebo)

Completed
Has Results
  • Healthy
  • Ad26.RSV.preF
  • +2 more
  • Mount Pleasant, South Carolina
    Coastal Carolina Research Center
Jul 22, 2021

COVID-19 Trial in Worldwide (SARS-CoV-2 recombinant protein vaccine Phase 2 Formulation 1, SARS-CoV-2 recombinant protein

Active, not recruiting
  • COVID-19
  • SARS-CoV-2 recombinant protein vaccine Phase 2 Formulation 1
  • +10 more
  • Birmingham, Alabama
  • +71 more
Jul 11, 2022

Head Neck Cancer, Melanoma, Breast Cancer Trial in Shanghai (Recombinant L-IFN adenovirus injection)

Recruiting
  • Head and Neck Cancer
  • +6 more
  • Recombinant L-IFN adenovirus injection
  • Shanghai, Shanghai, China
    Shanghai Fengxian District Central Hospital
Jan 16, 2022

Parkinson's Disease Trial run by the National Institute of Neurological Disorders and Stroke (NINDS) (Convection enhanced

Completed
  • Parkinson's Disease
  • Convection enhanced delivery/AAV2-GDNF
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 26, 2023

COVID-19 Trial in Singapore (Recombinant COVID-19 Vaccine (chimpanzee adenovirus vector) for Inhalation)

Not yet recruiting
  • COVID-19
  • Recombinant COVID-19 Vaccine (chimpanzee adenovirus vector) for Inhalation
  • Singapore, Singapore
    National University Hospital
Jan 29, 2023

COVID-19, SARS-CoV-2 Acute Respiratory Disease Trial in Spain (COVID-19 Vaccine HIPRA 40 ug/dose, Comirnaty (Pfizer-BioNtech) 30

Recruiting
  • COVID-19
  • SARS-CoV-2 Acute Respiratory Disease
  • COVID-19 Vaccine HIPRA 40 ug/dose
  • Comirnaty (Pfizer-BioNtech) 30 ug/dose concentrate for dispersion for injection
  • Coruña, Spain
  • +6 more
Jul 21, 2022

Unilateral Severe to Profound Hearing Loss OR Bilateral Severe to Profound Hearing Loss Trial in United States (CGF166)

Completed
Has Results
  • Unilateral Severe to Profound Hearing Loss OR Bilateral Severe to Profound Hearing Loss
  • Kansas City, Kansas
  • +3 more
Oct 7, 2021

Platinum-refractory Ovarian Carcinoma, Platinum-resistant Ovarian Cancer Trial in Rochester, Helsinki (TILT-123, Pembrolizumab)

Recruiting
  • Platinum-refractory Ovarian Carcinoma
  • Platinum-resistant Ovarian Cancer
  • TILT-123
  • Pembrolizumab
  • Rochester, Minnesota
  • +1 more
Aug 12, 2022

Infection Trial in Houston (Multivirus Specific T cells)

Completed
Has Results
  • Infection
  • Multivirus Specific T cells
  • Houston, Texas
  • +1 more
Jul 16, 2021

Acute Otitis Media Trial in Rochester (Tympanocentesis, Nasal Phalangeal Swab and Wash, Blood Draw)

Recruiting
  • Acute Otitis Media
  • Tympanocentesis
  • +2 more
  • Rochester, New York
    Rochester General Hospital
Nov 1, 2022

Recurring Glioblastoma Trial in Fujian (Recombinant L-IFN adenovirus injection)

Recruiting
  • Recurring Glioblastoma
  • Recombinant L-IFN adenovirus injection
  • Fujian, Fujian, China
    Binhai Hospital of Fujian Medical University
Jun 27, 2023

Adenovirus Infection in Children With Autoimmune Hepatitis

Not yet recruiting
  • Observational
  • Pcr
  • (no location specified)
Jan 20, 2023

Cholangiocarcinoma, Intrahepatic Trial in Beijing (Recombinant Human Adenovirus Type 5, HAIC of FOLFOX)

Not yet recruiting
  • Cholangiocarcinoma, Intrahepatic
  • Recombinant Human Adenovirus Type 5
  • HAIC of FOLFOX
  • Beijing, Beijing, China
    Beijing Tsinghua Chang Gung Hospital
Mar 16, 2022

Myeloid Hematological Malignancies Trial in Houston (Busulfan, Cyclophosphamide, Fludarabine)

Completed
Has Results
  • Myeloid Hematological Malignancies
  • Houston, Texas
    Texas Children's Hospital
May 13, 2022

Melanoma, Head and Neck Squamous Cell Carcinoma Trial in Helsinki (TILT-123, Avelumab)

Recruiting
  • Melanoma
  • Head and Neck Squamous Cell Carcinoma
  • Helsinki, Finland
    Docrates Cancer Center
Jul 12, 2022